Related Experiment Videos
Clinical experience with long-term cromolyn sodium administration in 53 asthmatic children
Insights
Cromolyn sodium effectively controlled severe childhood asthma by reducing symptoms and the need for other medications. This long-term inhalation therapy decreased hospitalizations and school absences in pediatric patients.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Severe asthma in children poses significant challenges to quality of life and requires effective long-term management strategies.
- Current treatments may have limitations or side effects, necessitating exploration of alternative or adjunctive therapies.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of inhaled cromolyn sodium in managing severe childhood asthma.
- To assess the impact of cromolyn sodium on asthma symptom control, medication requirements, and clinical outcomes.
Main Methods:
- A cohort of 53 severely asthmatic children received inhaled cromolyn sodium four times daily.
- Treatment duration ranged from 10 to 43 months with monthly follow-up visits.
- Data collected included symptom levels, medication use, hospitalizations, and school absences.
Main Results:
- Inhaled cromolyn sodium demonstrated significant effectiveness in controlling asthma symptoms like coughing, wheezing, and sleep disturbances.
- Patients experienced a reduced need for concomitant asthma medications, including corticosteroids.
- A notable decrease in hospitalizations and school absences was observed during the study period.
Conclusions:
- Long-term inhaled cromolyn sodium administration is an effective therapeutic option for severely asthmatic children.
- This treatment can lead to improved symptom control, reduced reliance on other asthma medications, and fewer adverse events such as hospitalizations and missed school days.
Abstract:
Cromolyn sodium was administered by inhalation four times a day to 53 severely asthmatic children for periods ranging from 10 to 43 months. The patients were seen at follow-up vists at least once a month through the entire study period. At the cut-off point of the study cromolyn sodium had been effective in controlling asthma by reducing the level of asthma symptoms, such as coughing, wheezing, sleep disturbance and sputum output. In addition there was a reduction in the patients' requirements for concomitant anti-asthma medications (including corticosteroids) and the number of hospitalizations and school absences.